Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Defibrillators, Implantable | 10 | 2017 | 265 | 1.280 |
Why?
|
| Nephritis, Hereditary | 1 | 2020 | 2 | 0.700 |
Why?
|
| Pacemaker, Artificial | 5 | 2015 | 49 | 0.690 |
Why?
|
| Cardiac Pacing, Artificial | 6 | 2023 | 37 | 0.670 |
Why?
|
| Aortic Aneurysm | 1 | 2020 | 87 | 0.640 |
Why?
|
| Electric Countershock | 4 | 2007 | 101 | 0.500 |
Why?
|
| Atrial Fibrillation | 8 | 2017 | 837 | 0.470 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2006 | 360 | 0.370 |
Why?
|
| Heart Failure | 4 | 2009 | 912 | 0.370 |
Why?
|
| Electric Power Supplies | 1 | 2010 | 6 | 0.340 |
Why?
|
| Cardiomyopathies | 3 | 2009 | 122 | 0.330 |
Why?
|
| Catheter Ablation | 4 | 2016 | 153 | 0.310 |
Why?
|
| Myocardial Ischemia | 2 | 2005 | 118 | 0.280 |
Why?
|
| Vena Cava, Superior | 1 | 2005 | 9 | 0.250 |
Why?
|
| Prosthesis Implantation | 1 | 2005 | 33 | 0.240 |
Why?
|
| Vena Cava, Inferior | 1 | 2005 | 32 | 0.240 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2017 | 16 | 0.230 |
Why?
|
| Heart Rate | 5 | 2010 | 321 | 0.220 |
Why?
|
| Bradycardia | 2 | 2023 | 33 | 0.210 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2016 | 57 | 0.210 |
Why?
|
| Male | 22 | 2020 | 29717 | 0.200 |
Why?
|
| Bundle of His | 1 | 2023 | 4 | 0.200 |
Why?
|
| Middle Aged | 17 | 2020 | 17480 | 0.200 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2015 | 152 | 0.200 |
Why?
|
| Ventricular Premature Complexes | 1 | 2002 | 21 | 0.190 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2002 | 36 | 0.190 |
Why?
|
| Pericardial Effusion | 1 | 2020 | 21 | 0.170 |
Why?
|
| Pulmonary Veins | 2 | 2015 | 38 | 0.170 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 43 | 0.170 |
Why?
|
| Aged | 17 | 2017 | 14333 | 0.160 |
Why?
|
| Humans | 27 | 2023 | 63152 | 0.160 |
Why?
|
| Electrocardiography | 4 | 2023 | 554 | 0.160 |
Why?
|
| Prospective Studies | 8 | 2017 | 3270 | 0.150 |
Why?
|
| Fluoroscopy | 1 | 1998 | 64 | 0.150 |
Why?
|
| Treatment Outcome | 8 | 2023 | 5625 | 0.140 |
Why?
|
| Rifampin | 1 | 2017 | 25 | 0.140 |
Why?
|
| Minocycline | 1 | 2017 | 27 | 0.140 |
Why?
|
| Prosthesis-Related Infections | 1 | 2017 | 34 | 0.130 |
Why?
|
| Atrial Function, Left | 1 | 2016 | 33 | 0.130 |
Why?
|
| Heart Conduction System | 2 | 2023 | 54 | 0.130 |
Why?
|
| Cost of Illness | 1 | 2017 | 163 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 2159 | 0.120 |
Why?
|
| Heart Atria | 1 | 2016 | 138 | 0.120 |
Why?
|
| Quality of Life | 2 | 2017 | 1223 | 0.120 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 33 | 0.120 |
Why?
|
| Spinal Diseases | 1 | 2015 | 48 | 0.120 |
Why?
|
| Female | 18 | 2017 | 32709 | 0.120 |
Why?
|
| Ventricular Fibrillation | 2 | 2007 | 106 | 0.120 |
Why?
|
| Equipment Failure | 2 | 2015 | 65 | 0.110 |
Why?
|
| Head | 1 | 2015 | 55 | 0.110 |
Why?
|
| Follow-Up Studies | 5 | 2017 | 2451 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 157 | 0.100 |
Why?
|
| Echocardiography | 1 | 2016 | 501 | 0.100 |
Why?
|
| Recurrence | 3 | 2016 | 639 | 0.100 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 332 | 0.100 |
Why?
|
| Mindfulness | 1 | 2013 | 70 | 0.100 |
Why?
|
| Sick Sinus Syndrome | 1 | 2011 | 5 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 72 | 0.090 |
Why?
|
| Time Factors | 5 | 2016 | 3754 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 784 | 0.090 |
Why?
|
| Anxiety | 1 | 2013 | 423 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 359 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2012 | 383 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 5429 | 0.080 |
Why?
|
| Endosonography | 1 | 2009 | 26 | 0.080 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 63 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2009 | 72 | 0.080 |
Why?
|
| Gastric Bypass | 1 | 2009 | 76 | 0.080 |
Why?
|
| Needles | 1 | 2009 | 67 | 0.080 |
Why?
|
| Prosthesis Failure | 1 | 2009 | 73 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2009 | 97 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2009 | 579 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2009 | 730 | 0.070 |
Why?
|
| Automobile Driving | 1 | 2007 | 54 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2009 | 410 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 341 | 0.060 |
Why?
|
| Equipment Design | 3 | 2015 | 345 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 129 | 0.060 |
Why?
|
| Survival | 1 | 2005 | 11 | 0.060 |
Why?
|
| Algorithms | 1 | 2010 | 1001 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2015 | 2560 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2005 | 136 | 0.050 |
Why?
|
| Erythema | 1 | 2003 | 13 | 0.050 |
Why?
|
| Pruritus | 1 | 2003 | 30 | 0.050 |
Why?
|
| Troponin I | 1 | 2003 | 36 | 0.050 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2023 | 2 | 0.050 |
Why?
|
| Microwaves | 1 | 2003 | 14 | 0.050 |
Why?
|
| Adult | 6 | 2015 | 16736 | 0.050 |
Why?
|
| Sex Factors | 2 | 2009 | 978 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2012 | 1121 | 0.040 |
Why?
|
| Skin | 1 | 2003 | 373 | 0.040 |
Why?
|
| Age Factors | 2 | 2009 | 1559 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 1082 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 5331 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2015 | 2066 | 0.040 |
Why?
|
| Exercise | 1 | 2007 | 939 | 0.040 |
Why?
|
| Maryland | 1 | 1998 | 35 | 0.040 |
Why?
|
| Survival Rate | 2 | 2012 | 846 | 0.040 |
Why?
|
| Prognosis | 2 | 2015 | 1741 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 1998 | 132 | 0.030 |
Why?
|
| Surgical Mesh | 1 | 2017 | 61 | 0.030 |
Why?
|
| Hematoma | 1 | 2017 | 79 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 114 | 0.030 |
Why?
|
| Incidence | 2 | 2011 | 1372 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 147 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 290 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 281 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2015 | 69 | 0.030 |
Why?
|
| Contraindications | 1 | 2015 | 51 | 0.030 |
Why?
|
| Cryosurgery | 1 | 2015 | 27 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2015 | 22 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2571 | 0.030 |
Why?
|
| Telephone | 1 | 2013 | 118 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 1375 | 0.030 |
Why?
|
| Registries | 1 | 2016 | 886 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1543 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2013 | 360 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 1393 | 0.020 |
Why?
|
| United States | 2 | 2017 | 7827 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1004 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 664 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2009 | 45 | 0.020 |
Why?
|
| Electricity | 1 | 2009 | 8 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2673 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 408 | 0.020 |
Why?
|
| Adolescent | 1 | 1998 | 6229 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 161 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2007 | 143 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2009 | 483 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1143 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2007 | 138 | 0.020 |
Why?
|
| Insulin | 1 | 2009 | 686 | 0.020 |
Why?
|
| Midazolam | 1 | 2004 | 12 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1645 | 0.010 |
Why?
|
| Anesthetics, Intravenous | 1 | 2004 | 26 | 0.010 |
Why?
|
| Conscious Sedation | 1 | 2004 | 39 | 0.010 |
Why?
|
| Fentanyl | 1 | 2004 | 76 | 0.010 |
Why?
|
| Thoracoscopy | 1 | 2003 | 25 | 0.010 |
Why?
|
| Hospitalization | 1 | 2007 | 1356 | 0.010 |
Why?
|